Skip to main content

Published locations for Omalizumab reduces epinephrine need during oral immunotherapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Omalizumab reduces epinephrine need during oral immunotherapy

User login

  • Reset your password
  • /content/omalizumab-reduces-epinephrine-need-during-oral-immunotherapy
  • /edermatologynews/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral
  • /familypracticenews/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral
  • /pediatricnews/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral-immunotherapy
  • /pulmonary-health-hub/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral
  • /pediatrics/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral-immunotherapy
  • /dermatology/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral-immunotherapy
  • /familymedicine/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral
  • /chestphysician/article/80712/pediatrics/omalizumab-reduces-epinephrine-need-during-oral